New drug trial targets dangerous sugar crashes after gastric bypass
Disease control
Completed
This study tested whether a medication called mizagliflozin could help control severe low blood sugar episodes that sometimes occur after weight-loss surgery. Fifteen people who had undergone gastric bypass and experienced these episodes tried the drug and a placebo in different …
Phase: PHASE2 • Sponsor: Vogenx, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC